These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33447611)

  • 21. Detection of Bacterial Colonization in Lung Transplant Recipients Using an Electronic Nose.
    Wijbenga N; de Jong NLA; Hoek RAS; Mathot BJ; Seghers L; Aerts JGJV; Bos D; Manintveld OC; Hellemons ME
    Transplant Direct; 2023 Oct; 9(10):e1533. PubMed ID: 37745948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Padilla RP; Thirión-Romero I; Ornelas-Rebolledo O; Flores-Ramírez R
    Respir Med; 2020 Mar; 163():105901. PubMed ID: 32125969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of electronic nose technology in chronic lung allograft dysfunction.
    Wijbenga N; Hoek RAS; Mathot BJ; Seghers L; Moor CC; Aerts JGJV; Bos D; Manintveld OC; Hellemons ME
    J Heart Lung Transplant; 2023 Feb; 42(2):236-245. PubMed ID: 36283951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.
    van der Schee MP; Palmay R; Cowan JO; Taylor DR
    Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. eNose technology can detect and classify human pathogenic molds in vitro: a proof-of-concept study of Aspergillus fumigatus and Rhizopus oryzae.
    de Heer K; Vonk SI; Kok M; Kolader M; Zwinderman AH; van Oers MH; Sterk PJ; Visser CE
    J Breath Res; 2016 Jul; 10(3):036008. PubMed ID: 27447026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations.
    Shafiek H; Fiorentino F; Merino JL; López C; Oliver A; Segura J; de Paul I; Sibila O; Agustí A; Cosío BG
    PLoS One; 2015; 10(9):e0135199. PubMed ID: 26353114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive breath monitoring with eNose does not improve glucose diagnostics in critically ill patients in comparison to continuous glucose monitoring in blood.
    Leopold JH; Bos LDJ; Colombo C; Sterk PJ; Schultz MJ; Abu-Hanna A
    J Breath Res; 2017 Apr; 11(2):026002. PubMed ID: 28260695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of transportation and storage using sorbent tubes of exhaled breath samples on diagnostic accuracy of electronic nose analysis.
    van der Schee MP; Fens N; Brinkman P; Bos LD; Angelo MD; Nijsen TM; Raabe R; Knobel HH; Vink TJ; Sterk PJ
    J Breath Res; 2013 Mar; 7(1):016002. PubMed ID: 23257711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy.
    Abdel-Aziz MI; Brinkman P; Vijverberg SJH; Neerincx AH; de Vries R; Dagelet YWF; Riley JH; Hashimoto S; Montuschi P; Chung KF; Djukanovic R; Fleming LJ; Murray CS; Frey U; Bush A; Singer F; Hedlin G; Roberts G; Dahlén SE; Adcock IM; Fowler SJ; Knipping K; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH; ;
    J Allergy Clin Immunol; 2020 Nov; 146(5):1045-1055. PubMed ID: 32531371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased day-to-day fluctuations in exhaled breath profiles after a rhinovirus challenge in asthma.
    Lammers A; Brinkman P; Te Nijenhuis LH; de Vries R; Dagelet YWF; Duijvelaar E; Xu B; Abdel-Aziz MI; Vijverberg SJ; Neerincx AH; Frey U; Lutter R; Maitland-van der Zee AH; Sterk PJ; Sinha A
    Allergy; 2021 Aug; 76(8):2488-2499. PubMed ID: 33704785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of classification methods in breath analysis by electronic nose.
    Leopold JH; Bos LD; Sterk PJ; Schultz MJ; Fens N; Horvath I; Bikov A; Montuschi P; Di Natale C; Yates DH; Abu-Hanna A
    J Breath Res; 2015 Dec; 9(4):046002. PubMed ID: 26669708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma.
    Brinkman P; Wagener AH; Hekking PP; Bansal AT; Maitland-van der Zee AH; Wang Y; Weda H; Knobel HH; Vink TJ; Rattray NJ; D'Amico A; Pennazza G; Santonico M; Lefaudeux D; De Meulder B; Auffray C; Bakke PS; Caruso M; Chanez P; Chung KF; Corfield J; Dahlén SE; Djukanovic R; Geiser T; Horvath I; Krug N; Musial J; Sun K; Riley JH; Shaw DE; Sandström T; Sousa AR; Montuschi P; Fowler SJ; Sterk PJ;
    J Allergy Clin Immunol; 2019 May; 143(5):1811-1820.e7. PubMed ID: 30529449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Non-Invasive Detection of Pulmonary Exacerbations in Disorders of Mucociliary Clearance with Breath Analysis: A Systematic Review.
    Nessen E; Toussaint B; Israëls J; Brinkman P; Maitland-van der Zee AH; Haarman E
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38929901
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
    Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
    Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nose in malignant mesothelioma-Prediction of response to immune checkpoint inhibitor treatment.
    Disselhorst MJ; de Vries R; Quispel-Janssen J; Wolf-Lansdorf M; Sterk PJ; Baas P
    Eur J Cancer; 2021 Jul; 152():60-67. PubMed ID: 34087572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of eNose technology in COVID-19 patients after hospitalization.
    van Raaij BFM; Veltman JD; Hameete JF; Stöger JL; Geelhoed JJM
    BMC Pulm Med; 2023 Apr; 23(1):134. PubMed ID: 37081422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.